Robin Mansukhani

CEO and Co-Founder of Deciduous Therapeutics, a venture backed start-up developing novel immunotherapies to treat age related diseases. Locally, he is an advisor to early stage biotechs, particularly in the Aging and CNS space. Previously, Robin co-founded and served as CEO of Alzeca Biosciences, an Alzheimer’s/CNS diagnostic imaging company which is supported by venture investors, the Alzheimer's Drug Discovery Foundation, and and an NIH Direct to Phase 2 Grant. Robin has been an invited keynote speaker both domestically and abroad, including TEDx. Previously Mr. Mansukhani worked in early stage venture capital at The Maple Fund and investment banking at Axiom Capital. In the community he co-founded BlueStamp Engineering, an intensive, project based engineering program for high school students in NYC, San Francisco, and Palo Alto. Robin has also served a term in AmeriCorps. Mr. Mansukhani holds a B.S. in Biochemistry from Case Western Reserve University.